1226692

Pillar5 Pharma Inc. — FEI 3000241849

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
December 15, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Arnprior (Canada)

Citations

IDCFRDescription
145221 CFR 211.113(b)Validation lacking for sterile drug products
184621 CFR 211.84(d)(3)Establish reliability of supplier's C of A
457621 CFR 211.192No written record of investigation